REG - FTSE Russell - Oncimmune Holdings

Oncimmune HoldingsAnnouncement

17/03/2025 19:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250317:nRSQ9925Aa&default-theme=true

RNS Number : 9925A  FTSE Russell  17 March 2025

 

Oncimmune Holdings (UK): Constituent Deletion

Changes in FTSE UK Index Series

17 March 2025

 Following the suspension and announcement of the intention to appoint
 administrators for Oncimmune Holdings (UK, constituent), please see details of
 affected indexes and effective dates below:

 

 Index                     Effective From

Start of Trading
 FTSE AIM All-Share Index  20 March 2025

 

 

 

 

 

 

 For further information please contact FTSE Russell Client Services at
 info@ftserussell.com (mailto:info@ftserussell.com) or call:

Australia  +61 (0) 2 7228 5659
 Hong Kong  +852 2164 3333
 Japan      +81 3 6441 1430
 London     +44 (0) 20 7866 1810
 New York   +1877 503 6437

 

 Alternatively please visit our website at lseg.com/ftse-russell
 (https://www.lseg.com/en/ftse-russell)

 Terms of Use (http://www.ftserussell.com/legal/website-terms-use) | Copyright
 © 2025 FTSE Russell

 

 

Alternatively please visit our website at lseg.com/ftse-russell
(https://www.lseg.com/en/ftse-russell)

 

Terms of Use (http://www.ftserussell.com/legal/website-terms-use) | Copyright
© 2025 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  FTSJRMATMTJBBAA